Method for treating a non-rhinorrhea cholinergic influenced secretion
OwnerKei Roger Aoki, Michael W. Graystoninventors
Life of this patent
Estimating the term…
Abstract
A method and composition for treating a patient suffering from an excessive glandular secretion includes administration to the patient of a therapeutically effective amount of a botulinum toxin type A, B, C, D, E, F and/or G.
Claims8
A method for treating an excessively secreting cholinergically influenced gland, the method comprising the step of injecting an excessively secreting cholinergically influenced gland, or the local area of the gland, with a botulinum toxin in order to reduce an excessive secretory activity of the gland, wherein the secretion is not a symptom of rhinorrhea.
A method for treating an excessively secreting cholinergically influenced gland, the method comprising the step of injecting an excessively secreting cholinergically influenced gland, or the local area of the gland, with a botulinum toxin type A in order to reduce an excessive secretory activity of the gland, wherein the secretion is not a symptom of rhinorrhea.
A method for treating an excessively secreting gland, the method comprising the step of injecting an excessively secreting gland, or the local area of the gland, with a botulinum toxin in order to reduce an excessive secretory activity of the gland, wherein the secretion is not a symptom of rhinorrhea.
Dependencies are inferred from the claim text.